Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000907939 | SCV001052671 | likely benign | Polyglandular autoimmune syndrome, type 1 | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003438573 | SCV004153791 | likely benign | not provided | 2023-06-01 | criteria provided, single submitter | clinical testing | AIRE: BP4, BP7 |
Natera, |
RCV000907939 | SCV001460097 | uncertain significance | Polyglandular autoimmune syndrome, type 1 | 2020-04-20 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003968347 | SCV004785716 | likely benign | AIRE-related disorder | 2021-04-26 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |